





IVY RX (ivyrx.com) is a Miami-based telehealth platform offering weight loss, anti-aging, and longevity treatments — with GLP-1 medications as its flagship product line. Founded by Phong Truong, a clinical pharmacist with experience at Option Care Health, Medical Monitoring Services, and Walgreens, IVY RX has grown into one of the larger direct-to-consumer GLP-1 telehealth providers, claiming 200,000+ patients served. The platform offers both compounded and brand-name GLP-1 medications, a notable advantage over many competitors that only provide one or the other.
Dual medication access is a standout feature — patients can choose between affordable compounded GLP-1s or brand-name Ozempic/Mounjaro through one platform, depending on preference, availability, and budget. Flat pricing at every dose means patients never face cost increases as their prescription is titrated up, making long-term budgeting predictable. The GLP-1 microdose program ($155/month for 4 doses) offers one of the lowest GLP-1 entry points on the market, accessible to patients with BMI 22+. Named pharmacy partners (Greenwich RX and ERXHub) following 503B/USP <797> standards provide transparency about medication sourcing that many competitors lack.
No lab work is required before prescribing GLP-1 medications. While this speeds up the process, it means thyroid function, kidney health, and other important markers that can affect GLP-1 safety are not screened upfront — a gap that third-party reviewers consistently flag. Brand-name options (Ozempic and Mounjaro) are prescribed off-label for weight loss rather than the FDA-approved weight loss formulations (Wegovy and Zepbound), which is common in telehealth but worth noting for patients who specifically want on-label prescriptions. BBB complaints include shipping delays (medication not arriving for weeks), billing charges after cancellation, and concerns about inconsistent or generic medical guidance — one complaint specifically described dosing responses as "uninformed" and potentially dangerous.
IVY RX is a well-established, high-volume GLP-1 telehealth platform with a strong Trustpilot reputation and a genuinely useful dual-access model offering both compounded and brand-name medications. The microdose program, flat pricing at every dose, named pharmacy partners, and broad wellness ecosystem make it a competitive option for patients who want flexible, medication-first weight loss care. The main trade-offs are no upfront lab work, no structured coaching or nutrition support, and BBB complaints around shipping and billing — concerns that are common across the telehealth GLP-1 space but still worth weighing. Best suited for self-directed patients who want affordable, convenient GLP-1 access with the option to add brand-name medications or complementary wellness therapies.
Yes. IVY RX prescribes both compounded and brand-name GLP-1 medications. Compounded options include semaglutide and tirzepatide — the same active ingredients found in Ozempic/Wegovy and Mounjaro/Zepbound respectively — prepared by licensed 503B/USP <797> pharmacy partners including Greenwich RX and ERXHub. Brand-name options include Ozempic (semaglutide) and Mounjaro (tirzepatide), prescribed off-label for weight loss. Compounded medications are not FDA-approved. IVY RX also offers a microdose GLP-1 program with lower starting doses for patients with BMI 22+.
IVY RX's weight-loss product page lists the following prices directly: GLP-1 Injections (compounded semaglutide) at $175/month, GLP-1 Microdose at $155/month, MIC + B12 Injection at $179, Metformin at $90/month, Anti-Nausea Tablets at $19.99, and GLP-1 Boost supplement at $72. Third-party reviewers report compounded tirzepatide at approximately $297–$495/month and brand-name Ozempic/Mounjaro at approximately $1,399/month, though these prices are not listed on the weight-loss page directly. All compounded plans feature flat pricing at every dose — costs do not increase as your prescription is titrated up. Multi-month plans offer reduced rates with upfront payment. There are no consultation fees or membership charges. Free shipping is included. Insurance is not accepted. Exact pricing for tirzepatide and brand-name options should be confirmed during intake as it may vary by plan length and current promotions.
IVY RX offers a dedicated microdose GLP-1 program starting at $155/month for 4 doses. Microdosing uses lower starting doses of semaglutide or tirzepatide with gradual, personalized increases — appealing to patients who want a gentler introduction to GLP-1 therapy or who have BMI as low as 22. The program includes medical evaluation, ongoing provider access, personalized dose guidance, and medication delivery. Microdosing may offer lower upfront monthly costs compared to standard dosing, though patients with higher BMI who ultimately need full therapeutic doses may take longer to reach effective levels.
No. IVY RX does not accept insurance for any of its services. All medications are paid out of pocket. HSA/FSA eligibility is not prominently confirmed on the main website but may be accepted — patients should confirm during checkout. Brand-name Ozempic and Mounjaro are available through IVY RX at cash-pay prices (~$1,399/month), though patients with insurance may find lower costs through traditional pharmacies or manufacturer savings programs.
Every IVY RX plan includes a free online health questionnaire, licensed provider evaluation and prescription (if approved), compounded or brand-name GLP-1 medication, all injection supplies, free discreet shipping, unlimited messaging with the clinical team, and access to the IVY RX app (weight tracking, meal planning, exercise logging, scheduling tools). There are no separate consultation fees or membership charges for compounded medication plans. IVY RX also offers add-on therapies including MIC + B12 injections ($179), Metformin ($90/month), Anti-Nausea Tablets ($19.99), GLP-1 Boost supplement ($72), NAD+ injections, glutathione, sermorelin, and BPC-157.